RN
FJTWAI
MK
STNI
PNPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Monterosatxmonterosatx.com STMK DB |
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medici | Boston, Massachusetts | 201-1000 | — |
Kymera Therapeuticskymeratx.com  NGEPJB |
Kymera Therapeutics is a clinical-stage biotechnology company pioneering targeted protein degradation (TPD) to develop oral small | Watertown, Massachusetts | 201-1000 | — |
C4Therapeuticsc4therapeutics.com SB  PM PC |
C4 Therapeutics (C4T, Nasdaq: CCCC) is a clinical-stage biopharmaceutical company developing targeted protein degradation medicine | Watertown, Massachusetts | 51-200 | — |
argenxargenx.com HDPUAV |
argenx is a global immunology company that engineers antibody-based medicines for severe autoimmune diseases by partnering with ac | Boston, Massachusetts | 1001-5000 | — |
Kymerakymera.com  JW |
Kymera is a sports and recreation company that builds the Kymera Body Board, the world's first and only electric-powered bodyboard | McKinney, Texas | 11-50 | — |
C4Xdiscoveryc4xdiscovery.com  NR SMSK |
— | — | — | |
Nurixnurix.com |
— | — | — | |
Kyvernakyverna.com |
— | — | — | |
C4Xbioc4xbio.com |
— | — | — | |
Kymera Therapeuticskymera-therapeutics.com |
— | — | — | |
C4Xhealthcarec4xhealthcare.com |
— | — | — | |
| Run live for more | ||||
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines targeting undruggable proteins in oncology, autoimmune, and inflammatory diseases. The company uses its QuEEN™ discovery engine — combining AI-guided chemistry, structural biology, and proteomics — to identify degradable protein targets and rationally design MGDs with unprecedented selectivity.
Companies like Monte Rosa Therapeutics include Kymera Therapeutics, C4Therapeutics, argenx, Kymera, C4Xdiscovery. See the full list of 24 competitors and alternatives above.
Monte Rosa Therapeutics has approximately 201-1000 employees and is in the Biotechnology Research industry.
Monte Rosa Therapeutics is headquartered in Boston, Massachusetts.
Monte Rosa Therapeutics operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Monte Rosa Therapeutics are listed above, including leaders across executive, finance, sales and operations.